Loading company…
Mytos Bio automates cell culture workflows and develops equipment for human cell production and drug discovery.
Mytos Bio develops a digital platform and equipment to automate the production of human cell types and cell culture workflows for drug discovery. Its platform also automates methods for generating neural progenitor cells used in disease modelling. The company is based in London, UK. In November 2023, it raised USD 19 million in Series A funding led by Buckley Ventures, with participation from IQ Capital and Wing VC.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in